» Articles » PMID: 33805680

Recent Advances and Trends in Chemical CPP-Drug Conjugation Techniques

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Apr 3
PMID 33805680
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

This review summarizes recent developments in conjugation techniques for the synthesis of cell-penetrating peptide (CPP)-drug conjugates targeting cancer cells. We will focus on small organic molecules as well as metal complexes that were used as cytostatic payloads. Moreover, two principle ways of coupling chemistry will be discussed direct conjugation as well as the use of bifunctional linkers. While direct conjugation of the drug to the CPP is still popular, the use of bifunctional linkers seems to gain increasing attention as it offers more advantages related to the linker chemistry. Thus, three main categories of linkers will be highlighted, forming either disulfide acid-sensitive or stimuli-sensitive bonds. All techniques will be thoroughly discussed by their pros and cons with the aim to help the reader in the choice of the optimal conjugation technique that might be used for the synthesis of a given CPP-drug conjugate.

Citing Articles

Exploring the Chemical Features and Biomedical Relevance of Cell-Penetrating Peptides.

Moreno-Vargas L, Prada-Gracia D Int J Mol Sci. 2025; 26(1.

PMID: 39795918 PMC: 11720145. DOI: 10.3390/ijms26010059.


Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets.

Colas K, Bindl D, Suga H Chem Rev. 2024; 124(21):12213-12241.

PMID: 39451037 PMC: 11565579. DOI: 10.1021/acs.chemrev.4c00422.


Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders.

Wu Y, Angelova A Nanomaterials (Basel). 2023; 13(23).

PMID: 38063700 PMC: 10708303. DOI: 10.3390/nano13233004.


Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier (BBB).

Ghorai S, Deep A, Magoo D, Gupta C, Gupta N Pharmaceutics. 2023; 15(7).

PMID: 37514185 PMC: 10384895. DOI: 10.3390/pharmaceutics15071999.


Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress.

Sun Z, Huang J, Fishelson Z, Wang C, Zhang S Biomedicines. 2023; 11(7).

PMID: 37509610 PMC: 10377493. DOI: 10.3390/biomedicines11071971.


References
1.
Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K . Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem. 2000; 276(8):5836-40. DOI: 10.1074/jbc.M007540200. View

2.
Smilowicz D, Metzler-Nolte N . Bioconjugates of Co(III) complexes with Schiff base ligands and cell penetrating peptides: Solid phase synthesis, characterization and antiproliferative activity. J Inorg Biochem. 2020; 206:111041. DOI: 10.1016/j.jinorgbio.2020.111041. View

3.
Yu M, Li X, Liang R, Yang J, Zhang Y, Wang H . A new ligand of CD105 screened out by phage display technology provides a reliable identification of recurrent or metastasizing pleomorphic adenoma from pleomorphic adenoma. Int Immunopharmacol. 2018; 65:37-43. DOI: 10.1016/j.intimp.2018.09.042. View

4.
Balogh B, Ivanczi M, Nizami B, Beke-Somfai T, Mandity I . ConjuPepDB: a database of peptide-drug conjugates. Nucleic Acids Res. 2020; 49(D1):D1102-D1112. PMC: 7778964. DOI: 10.1093/nar/gkaa950. View

5.
Gamcsik M, Kasibhatla M, Teeter S, Colvin O . Glutathione levels in human tumors. Biomarkers. 2012; 17(8):671-91. PMC: 3608468. DOI: 10.3109/1354750X.2012.715672. View